Hologic, Inc. (HOLX): Price and Financial Metrics


Hologic, Inc. (HOLX)

Today's Latest Price: $57.86 USD

0.89 (1.56%)

Updated Jul 2 4:00pm

Add HOLX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

HOLX Stock Summary

  • HOLX has a market capitalization of $14,717,723,646 -- more than approximately 89.24% of US stocks.
  • HOLX's went public 30.29 years ago, making it older than 84.66% of listed US stocks we're tracking.
  • Over the past twelve months, HOLX has reported earnings growth of 413.75%, putting it ahead of 96.67% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Hologic Inc are WAB, FMC, IFF, PRGO, and ENTG.
  • HOLX's SEC filings can be seen here. And to visit Hologic Inc's official web site, go to www.hologic.com.
HOLX Daily Price Range
HOLX 52-Week Price Range

HOLX Stock Price Chart Technical Analysis Charts


HOLX Price/Volume Stats

Current price $57.86 52-week high $58.72
Prev. close $56.97 52-week low $26.49
Day low $57.54 Volume 3,008,756
Day high $58.72 Avg. volume 2,795,436
50-day MA $52.29 Dividend yield N/A
200-day MA $48.97 Market Cap 14.94B

Hologic, Inc. (HOLX) Company Bio


Hologic Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company was founded in 1985 and is based in Bedford, Massachusetts.

HOLX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$57.86$23.93-55%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Hologic Inc. To summarize, we found that Hologic Inc ranked in the 28th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Hologic Inc, consider:

  • Hologic Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 7. This value is greater than just 21.45% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-56%
1%-56%
2%-55%
3%-55%
4%-54%
5%-54%

ABT, ESMC, BHC, CNMD, and IONS can be thought of as valuation peers to HOLX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


HOLX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

HOLX Latest Social Stream


Loading social stream, please wait...

View Full HOLX Social Stream

Latest HOLX News From Around the Web

Below are the latest news stories about Hologic Inc that investors may wish to consider to help them evaluate HOLX as an investment opportunity.

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2020 on Wednesday, July 29, 2020

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #earnings--Hologic to Announce Financial Results for the Third Quarter of Fiscal 2020 on Wednesday, July 29, 2020

Business Wire | July 2, 2020

QIAGEN's (QGEN) Selloff Deal With Thermo Fisher Progresses

QIAGEN's (QGEN) acquisition deal with Thermo Fisher receives approval from QIAGEN shareholders.

Yahoo | July 1, 2020

Hologic Stock Rides High on Strength of Coronavirus Testing

Hologic has carved out a meaningful niche in women's health. But it's coronavirus testing driving HOLX stock higher these days.

InvestorPlace | June 30, 2020

Abbott, Tandem Diabetes Seal Deal on Diabetes Management

Abbott's (ABT) FreeStyle Libre CGM technology to be integrated with Tandem Diabetes' insulin pumps to enhance diabetes care.

Yahoo | June 30, 2020

Braveheart Resources Engages Investor Relations Advisor

Calgary, Alberta--(Newsfile Corp. - June 30, 2020) - Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) ("Braveheart" or, the "Company") hereby announces the engagement of GRA Enterprises LLC for the provision of investor relations services pursuant to a consulting agreement dated June 5, 2020. Services include the production and publication of investor relations bulletins, distribution of investor bulletins to the consultant's e-mail list, and posts through the consultant's blogs and social media accounts. ...

Yahoo | June 30, 2020

Read More 'HOLX' Stories Here

HOLX Price Returns

1-mo 10.59%
3-mo 76.29%
6-mo 10.46%
1-year 20.64%
3-year 28.12%
5-year 50.91%
YTD 10.82%
2019 27.03%
2018 -3.86%
2017 6.56%
2016 3.70%
2015 44.69%

Continue Researching HOLX

Want to see what other sources are saying about Hologic Inc's financials and stock price? Try the links below:

Hologic Inc (HOLX) Stock Price | Nasdaq
Hologic Inc (HOLX) Stock Quote, History and News - Yahoo Finance
Hologic Inc (HOLX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0981 seconds.